Shed urinary ALCAM is an independent prognostic biomarker of three-year overall survival after cystectomy in patients with bladder cancer.
Arnold Egloff SA, Du L, Loomans HA, Starchenko A, Su PF, Ketova T, Knoll PB, Wang J, Haddad AQ, Fadare O, Cates JM, Lotan Y, Shyr Y, Clark PE, Zijlstra A.
Arnold Egloff SA, et al. Among authors: loomans ha.
Oncotarget. 2017 Jan 3;8(1):722-741. doi: 10.18632/oncotarget.13546.
Oncotarget. 2017.
PMID: 27894096
Free PMC article.